Skip to content
  • Australia
    • Global
    • United Kingdom
    • Australia
  • Contact
  • Investor Centre
Menu
  • Australia
    • Global
    • United Kingdom
    • Australia
  • Contact
  • Investor Centre
  • Discover
        • Discover

          Discover how we are creating a pipeline of plant-based medicines supported by a robust clinical trial agenda, changing the paradigm of natural treatments across the globe.

        • Plant-Based Medicines
        • Our Global Product Offering
        • Clinical Trials
  • About
        • About

          The ethos behind MGC Pharma, plans for the future, and a view into the people and ideas that make our company work.

        • Our Story
        • Vision and Values
        • Our Team
        • Future Roadmap
  • Research
        • Research

          Explore available research and information on plant-based medicines, as the market is rapidly maturing.

        • Research and Development
        • Research Hub

ASX:MXC

Search
Close
  • Discover
    • Clinical Trials
    • Our Global Product Offering
    • Plant-Based Medicines
  • About
    • Our Story
    • Our Vision and Values
    • Our Team
    • Future Roadmap
  • Research
    • Research and Development
    • Research Hub
  • Investor Centre
  • Contact
  • Global
    • Global
    • United Kingdom
    • Australia
Menu
  • Discover
    • Clinical Trials
    • Our Global Product Offering
    • Plant-Based Medicines
  • About
    • Our Story
    • Our Vision and Values
    • Our Team
    • Future Roadmap
  • Research
    • Research and Development
    • Research Hub
  • Investor Centre
  • Contact
  • Global
    • Global
    • United Kingdom
    • Australia
Search
Close

Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma…

Discover
  • Plant-Derived Medicines
  • Products & Treatments
  • Clincial Trials
About
  • Our Story
  • Vision & Values
  • Our Team
  • Future Roadmap
Research
  • Research & Development
  • Research Hub
  • FAQs
Investor Center
  • London Stock Exchange
  • Australian Stock Exchange
Home
Contact
Connect
Connect
Discover
  • Plant-Derived Medicines
  • Products & Treatments
  • Clincial Trials
About
  • Our Story
  • Vision & Values
  • Our Team
  • Future Roadmap
Research
  • Research & Development
  • Research Hub
  • FAQs
Investor Center
  • London Stock Exchange
  • Australian Stock Exchange
Contact
Home

© 2022 MGC Pharma . All Rights Reserved.
Website by Oliver Agency.

  • Disclaimer
  • Privacy Policy
  • Cookie Policy

ABN: 30 116 800 269 / LSE:MXC / ASX:MXC 

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie PolicyCookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT
View LinkedIn profile

Rob Clements

Chief Commercial Officer

After starting his career with an initial spell in the City of London Rob joined the pharmaceutical industry in 1991. Over the following decade he progressed rapidly through field roles to Marketing Management. He then established his own consultancy specialising in relationship marketing and product launch for healthcare companies.

He subsequently worked in business development roles identifying potential product acquisitions – both prescription and OTC – the development and launch of medical devices and general strategic functions. His roles included improving business performance and company morale, and oversight of companies’ core marketing of ethical brands.

From 2011 Rob headed a pan-national team for Forest Laboratories delivering new ethical products to markets alongside management of the existing portfolio. As Director both of Marketing and Commercial operations he was also directly responsible for budgeting, planning and data provision, whilst remaining closely involved with the assessment of BD opportunities.

An expert in specialist disease marketing and business development Rob has also worked extensively on a number of proposed private equity asset buyouts in addition to previous consultancy work.

From 2019 he worked with Healthcare at Home (now Sciensus Rare) to help establish an international rare medicines division. As Vice President of Business Development his role included ongoing development and refinement of the service offering and building new business opportunities; from strategic partnerships and potential MA acquisitions through to establishing Sciensus Rare’s global footprint.

Please share your location to continue.

Check our help guide for more info.

share your location